Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Ashmore sees $4bn of outflows in first quarter

(Sharecast News) - Shares in Ashmore dropped sharply on Monday after the emerging markets-focused asset manager reported a 5% drop in assets under management (AUM) over the first quarter of 2025. However, the company said that while market volatility has heightened since the period-end as a result of an escalating trade war, its business model remains well placed to deal as investors rebalance their portfolios away from the US.

AUM totalled $46.2bn by 31 March, down $2.6bn over the first three months of the year, comprising a positive investment performance of $1.3bn, offset by net outflows of $3.9bn.

Ashmore blamed the outflows on a small number of large institutional redemptions towards the end of the period in the local currency theme, reflecting client specific asset allocation decisions.

Chief executive Mark Coombs said: "These decisions do not appear indicative of a broader pattern of client activity and encouragingly, levels of investor interest in Ashmore's emerging markets fixed income and equity strategies continue to be strong."

Ashmore noted that recent market volatility since the start of this month has resulted in a 1% decline in the US Treasury index and a 2% fall in US high-yield bonds - though emerging markets fixed income has fallen by less than 2% and emerging markets equities have performed in line with the US.

"This resilience demonstrates that there are increasingly powerful reasons for investors to rebalance their asset allocations away from the US capital markets, such as tighter fiscal policy and a smaller government in the US, the start of fiscal stimulus in Europe, higher rates in Japan and China's focus on boosting domestic demand," Coombs said.

"When combined with the impact of aggressive trade tariffs, these factors point to a weaker US dollar, which will be supportive for the performance of emerging markets."

Despite the optimism, Ashmore's share price was down 5.7% at 126.1p by 0914 GMT.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.